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An alkaloid is a class of naturally occurring organic nitrogen-containing compounds that
are frequently found in the plant kingdom. Many alkaloids are valuable medicinal agents
that can be utilized to treat various diseases including malaria, diabetics, cancer, cardiac
dysfunction etc. Similarly, platelet aggregation beyond the purpose of homeostasis is
the underlying cause of blood clotting related diseases. This review presents a thorough
understanding of alkaloids as antiplatelet agents with a possible mechanism of action
based on the literature of the last decade. In addition, this review will address the
antiplatelet activity of alkaloids and their medicinal usage as potent antiplatelet agents
with a description of structural relationship activity and possible lead compounds for
future drug discovery.
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INTRODUCTION
Platelets (thrombocytes) are small irregularly shaped anuclear cells. The resting platelets circulate
in the blood in discoid shape which is changed upon activation. When blood vessels are damaged
or injured, platelets rush and form aggregates at the site of injury to stop the bleeding and this
is facilitated by their binding to the exposed activated thrombin receptor (Warfarin Antiplatelet
Vascular Evaluation Trial Investigators et al., 2007; Holmes Jr et al., 2009). Blood platelets are
involved in normal homeostasis. The normal homeostatic system limits blood loss by regulated
interaction between components of the vessel wall, circulating blood platelets and plasma proteins.
Platelets play an important role in the development of cardiovascular diseases. Arterial thrombosis
is an acute complication that develops on chronic lesions of atherosclerosis that results in a
heart attack and stroke. These chronic inflammatory processes are the central pathophysiological
mechanism by which lipid accumulation provides substrates for occlusive thrombus formation
(Jackson et al., 2003; Aradi et al., 2013). Some drugs used to treat inflammation may cause the
undesired side effect of suppressing normal platelet function, therefore, there is always a need for
alternative medicines to deal with such cases.
It is estimated that about 80% of the population of developing countries meet their primary
health care needs mainly through plant-based traditional healing (Amin and Khan, 2016). Different
parts of medicinal plants, rarely the whole plant, are mostly used in the preparation of traditional
medicines (Khan, 2014a,b). For so many years, despite criticisms, traditional medicine has gained
tremendous revival. Not only traditional healers provide immediate health care to the rural
population, but also play an important role in providing leads to the discovery of pharmacologically
active plant-derived compounds (Butler, 2008; Khan and Rauf, 2014).
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Alkaloids are small organic molecules, secondary metabolites
of plants, containing nitrogen usually in a ring; about 20% of
plant species consist of alkaloids (Amirkia and Heinrich, 2014;
Khan, 2016a). Alkaloids are mainly involved in the plant defense
against herbivores and pathogens. They are pharmaceutically
significant, traditional and modern uses of alkaloids are 25
to 75% in drugs, indicating their great therapeutic potential
(Khan, 2016b; Pervez et al., 2016). The basic character of
alkaloids is no longer a pre-requisite for an alkaloid and the
chemistry of nitrogen atoms allows at least four groups of
nitrogenous compounds. Some synthetic compounds of similar
structures are also termed as alkaloids (Khan et al., 2016).
Some alkaloids are free bases while others form salts with
organic acids such as oxalic and acetic acids. Some plant
alkaloids are present in a glycosidic form such as solanine
in solanum. The Alkaloid biosynthesis pathway is specifically
involved in the decarboxylation of compounds (Grynkiewicz
and Gadzikowska, 2008). Medicinal plants are a rich source of
alkaloids having antiplatelet and anticoagulant activities. The
commonly used antiplatelet, aspirin, originated from salicin
obtained from willow plant commonly used in pain medication.
This review describes various alkaloids isolated from plant
sources having antiplatelet activity with possible mechanisms and
candidates for further detailed studies in the drug discovery as
antiplatelet agents.
ALKALOIDS AS ANTIPLATELET AGENTS
In addition to synthetic drugs, several alkaloids have been
utilized as antiplatelet agents (Table 1). Rutaecarpine, an alkaloid
isolated from Evodia rutaecarpa, exhibited significant antiplatelet
activity which was further augmented by its derivatives,
2,3-methylenedioxyrutaecarpine, 3-chlororutaecarpine and 3-
hydroxyrutaecarpine by interfering with different mediators of
clot formation (Sheu et al., 1996; Son et al., 2015). This change
in activity was attributed to hydroxyl and methoxy groups
substitution. Park along with his Korean research fellows isolated
four acid amides (piperine, pipernonaline, piperoctadecalidine,
and piperlongumine) from Piper longum L. (Park et al., 2007).
The isolated compounds evoked marked antiplatelet effect
in a concentration-dependent manner. Of the isolated lot,
piperlongumine was most potent by acting through multiple
ways. Later on, piperlongumine was used as a lead compound and
its various derivatives were synthesized and exhibited a potential
inhibitory effect on washed rabbit platelet aggregation induced
by collagen, arachidonic acid (AA), and platelet activating
factor (PAF). On the other hand, 1-(3,5-dimethylpiperidin-
1-yl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one was reported
to have the most inhibitory effect on platelet aggregation
induced by collagen. This compound showed 100% inhibition
at a concentration of 150 and 300µM (Park et al., 2008).
In addition, a group of researchers in 2010 extracted several
alkaloids including veratroylgermine from Veratrum dahuricum.
This compound was found to produce the strongest inhibition
of the platelet aggregation induced by arachidonic acid with an
inhibition rate of 92.0% at 100µM (Tang et al., 2010). Similarly,
Li et al. (2002) obtained six alkaloids including spiramine C1
from Spiraea japonica. This diterpene alkaloid was reported
to inhibit PAF-induced platelet aggregation (Li et al., 2002).
Moreover, spiramine C1 inhibited platelet aggregation induced
by PAF, ADP, and arachidonic acid with IC50 values of 30, 56, and
29.9µM, respectively, in a concentration-dependent manner;
suggesting a non-selective antiplatelet aggregation action. In
addition, the inhibitory effect of spiramine C1 on arachidonic
acid was comparable to that of aspirin suggesting a strong
potential of this compound as a lead in the drug discovery against
platelet aggression.
In 2009, a group of researchers discovered that β-carboline
alkaloids obtained from Preganum harmala possess good
antiplatelet activity. Among the isolated β-carboline alkaloids,
harmane and harmine were the most potent with IC50 values
of 113.7 and 132.9µM, respectively, whereas harmol possessed
medium potency with an IC50 value of 200µM (Im et al.,
2009). In terms of structure-activity relationship on these
compounds’ inhibition of platelet aggregation, it is assumed
that the double bond in the C4–C9 position of the tricyclic
aromatic structure confers a basal inhibition on collagen-induced
platelet aggregation, as harmaline and harmalol showed the
weakest antiplatelet activity, both of which lack such a double-
bond. Introducing a methyl group at the C13 position could
strengthen such an inhibition as norharmane was much weaker
than harman. In addition, the antiplatelet potency varied with the
nature of groups at C1 position.
Similarly, Kuo and colleagues found that romucosine,
romucosine A, romucosine C, romucosine D and tuduranine,
phenanthrene type of alkaloids, extracted from Rollinia mucosa
Baill possessed a good antiplatelet activity (Kuo et al., 2001, 2004).
It has been observed thatmethoxyl substitution of C-10 enhanced
the activity more than hydroxyl substitution.
On the other hand, leonurine, isolated from the aerial part
of Leonurus sibircus var. albiflora by Hang and coworkers,
significantly inhibited rabbit platelet aggregation induced
by thrombin, arachidonic acid, and collagen in vitro with
IC50 values of 97.22, 31.03, and 44.48µM, respectively (Lin
et al., 2007). Furthermore, the methanol extract of Cassytha
filiformis was found to contain cathafiline, cathaformine,
actinodaphnine, predicentrine, and ocoteine. These alkaloids
exhibited remarkable vasorelaxant and inhibitory effects on the
platelet aggregation in washed rabbit platelets induced by ADP
(20µm), arachidonic acid (100µM), collagen (10µM), and PAF
(3.6 nM), respectively. All six alkaloids showed antiplatelet effects
to varying extent (Wu et al., 1998). In a paper published by Chen
et al. (2000), it was reported that the trunk bark of Hernandia
nymphaefolia possessed strong antiplatelet aggregation in vitro
due to the presence of six alkaloids: laurotetanine, oxohernagine,
thallicarpine, reticulline, vateamine, and hernandaline. The most
potent alkaloid was oxohernagine with 90% inhibition whereas
laurotetanine exhibited 87% inhibition at a concentration of
100µM. On the other hand, thalicarpine caused cell lysis at a
concentration of 100µM and showed 65% inhibition of platelet
aggregation (Chen et al., 2000). Rahman et al. (1991) showed
that ajmaline and acetyl ajmaline present as minor alkaloids
in the Rauvolfia serpentina selectively inhibited PAF-induced
aggregation in a concentration-related manner. Similarly,
ajmaline or acetyl ajmaline also inhibited the lethal effects of PAF
in rabbits; PAF (8–11µg/kg i.v.) caused sudden death in rabbits
Frontiers in Pharmacology | www.frontiersin.org 2 September 2016 | Volume 7 | Article 292
Ain et al. Alkaloids as Antiplatelet
TABLE 1 | The alkaloids isolated from plant with antiplatelet activities.
S. No Plant name Chemical structure References
1 Evodia rutaecarpa Asahina and Mayeda,
1916; Son et al., 2015
2 Piper longumine Park et al., 2007
3 Veratrum dahuricum Tang et al., 2010
4 Spiraea japonica Li et al., 2002
5 Perganum harmala Im et al., 2009
(Continued)
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TABLE 1 | Continued
S. No Plant name Chemical structure References
6 Rollinia mucosa Kuo et al., 2001, 2004
(Continued)
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TABLE 1 | Continued
S. No Plant name Chemical structure References
7 Leonurus sibiricus Lin et al., 2007
8 Cassytha filiformis L Wu et al., 1998
9 Hernandia nymphaefolia Chen et al., 2000
(Continued)
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TABLE 1 | Continued
S. No Plant name Chemical structure References
10 Rauwolfia serpentine Rahman et al., 1991
11 Carcuma aromatic Jantan et al., 2008
12 Illigera luzonensis Merr Huang et al., 2014
13 Melicope semecarpifolia Chen et al., 2001
(Continued)
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TABLE 1 | Continued
S. No Plant name Chemical structure References
14 Berberis Chu et al., 1996
15 Ruta graveolens Wu et al., 2003
due to platelet aggregation and cardiac failure (Rahman et al.,
1991; Unnikrishnan and Nishteswar, 2015).
In an investigation conducted by Jantan et al. (2008),
curcumin was isolated from Curcuma Aromatica. This alkaloid
showed strong inhibition of platelet aggregation induced by
arachidonic acid with an IC50 value of <84µM. Moreover,
curcumin was the most effective antiplatelet compound as it
inhibited arachidonic acid, collagen, and ADP-induced platelet
aggregation with IC50 values of 37.5, 60.9, and 45.7µM,
respectively (Jantan et al., 2008). Similarly, Huang et al.
(2014) reported that aporphine alkaloids are the primary
components of Illigeralu zonensis, exhibited varying degrees
of antiplatelet activity effect. However, bisdehydroaporphine
and actinodaphnine were most potent alkaloids (Huang et al.,
2014). Furthermore, a study carried out by Wu et al. (2003)
on Rutagra graveolens, a plant belonging to family Rutaceae
revealed the presence of dictamine, chalepensin, clausindin, and
graveolinine; these compounds displayed significant inhibition
of platelet aggregation(Wu et al., 2003). On the other hand,
Huang et al. (2014) discovered that the plant Illigera luzonensis
Merr contains aporphine alkaloids. These researchers also found
that actinodaphnine, which belongs to aporphine alkaloids,
exhibited significant inhibition of the aggregation of washed
rabbit platelets with an IC50 value in the range of 50–20µg/mL
(Huang et al., 2014). Furthermore, Chen et al. (2001) isolated
three new quinoline alkaloids from the root bark of Melicope
semecarpifolia along with 26 known compounds. Several of these
isolated compounds exhibited significant antiplatelet inhibition
against arachidonic acid-induced aggregation, collagen-induced,
and PAF-induced aggregation (Chen et al., 2001).
Altogether, these findings showed the potential of plant
alkaloids as antiplatelet agents or lead compounds. Most recently,
Lee et al. (2016) isolated and characterized alkaloids from
Scolopendra subspinipes mutilans, a product registered in various
Pharmacopeia (Lee et al., 2016). The isolated alkaloids showed
antithrombotic and antiplatelet activities in vitro and in vivo,
so that they appeared as strong candidates or lead compounds.
However, detailed studies are suggested for the reported plant-
alkaloids discovery of molecules of clinical utility. A Taipei
research group in 2003 isolated various components from Ruta
graveolens including clausindin, dictamine, and graveoline. they
showed strong antiplatelet activity against various mediators of
clot formation (Wu et al., 2003). Different structural parameters
of these alkaloids were unable to describe structural relationship
activity.
ANTIPLATELET MECHANISM OF PLANT
ALKALOIDS
Various mechanisms have been proposed for the antiplatelet
activity of different isolated plant-alkaloids (Figure 1).
Researchers have proposed that berberine significantly inhibited
platelet aggregation by inhibiting synthesis of thromboxane
A2 induced by adenine diphosphate, arachidonic acid, collagen
(Chu et al., 1996). In addition, clausine-D, isolated from
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FIGURE 1 | Proposed mechanism of alkaloids as antiplatelet.
Clausena excavate, displayed antiplatelet effect by inhibition
of thromboxane A2 formation. Higher concentration of
clausine-D (150µM) produced almost complete inhibition
of collagen-induced platelet aggregation (Wu et al., 1994).
Similarly, hernandaline and apomorphine alkaloids exhibited
antiplatelet activity by complete inhibition of platelet aggregation
induced by PAF at 50µg/mL, whereas reticuline completely
inhibited arachidonic acid and collagen-induced platelet
aggregation (Chen et al., 2000). On the other hand, phylligenin
alkaloid showed strong dose-dependent inhibitory activity. The
β-carboline alkaloids selectively inhibited PLCgamma2 and
protein tyrosine phosphorylation with sequential suppression of
cytosolic calcium mobilization and arachidonic acid liberation
(Im et al., 2009), indicating that harmane and harmine have a
potential to be developed as novel agents for atherothrombotic
diseases.
Based on the literature, the alkaloids isolated from various
sources provoked antiplatelet activity generallymediated through
multiple mechanisms, different from aspirin which is a
cyclooxygenase inhibitor (Chen et al., 2000) and thus expressed
their widespread potential as new effective agents of the class or
as lead compounds.
CONCLUSION
From the above literature review, it is concluded that alkaloids
are present abundantly and in high concentrations in natural
medicinal plants and several of them possess antiplatelet
activity. Moreover, the most important and effective alkaloids
found that can be used as antiplatelet agents are curcumin,
reticulin, piperlongumine, and melicarpinone that can be used
as antiplatelet agents. From a mechanistic point of view, they
are very versatile and interfere with various mediators of clot
formation, unlike aspirin which is a cyclooxygenase inhibitor.
In this regard, these agents are special candidates for further
detailed studies to ascertain their clinical utility and could be lead
compounds for better antiplatelet activity.
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